The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch
Open accessAbstract
To identify itch-related mediators and receptors that are differentially expressed in pruritic skin, we used RNA sequencing to analyze the complete transcriptome in skin from paired itchy, lesional and nonitchy, nonlesional skin biopsies from 25 patients with atopic dermatitis and 25 patients with psoriasis and site-matched biopsies from 30 healthy controls. This analysis identified 18,000 differentially expressed genes common between itchy atopic and psoriatic skin compared with healthy skin. Of those, almost 2,000 genes were differentially expressed between itchy and nonitchy skin in atopic and psoriatic subjects. Overexpression of several genes, such as phospholipase A2 IVD, substance P, voltage-gated sodium channel 1.7, and transient receptor potential (TRP) vanilloid 1, in itchy skin was positively correlated with itch intensity ratings in both atopic dermatitis and psoriasis. Cytokines such as IL-17A, IL-23A, and IL-31 had elevated gene transcript levels in both itchy atopic and psoriatic skin. However, expression of genes for TRP vanilloid 2, TRP ankyrin 1, protease-activated receptor 2, protease-activated receptor 4, and IL-10 was found to be increased only in pruritic atopic skin, whereas expression of genes for TRP melastatin 8, TRP vanilloid 3, phospholipase C, and IL-36α/γ was elevated only in pruritic psoriatic skin. This "itchscriptome" analysis will lead to an increased understanding of the molecular mechanisms of chronic pruritus and provide targets for itch treatment irrespective of disease state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, J.-H., Park, C.-K., Chen, G., Han, Q., Xie, R.-G., Liu, T., Ji, R.-R., & Lee, S.-Y. (2014) · Cell · doi:10.1016/j.cell.2014.03.064 · Cited by 207
RetractedRNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
McNeil, B. D., Pundir, P., Meeker, S., Han, L., Undem, B. J., Kulka, M., & Dong, X. (2015) · Nature · doi:10.1038/nature14022 · Cited by 1,228
Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
Self-citationAnti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592 · cited 1×
“Likewise, the IL-31 receptor-targeting drug nemolizumab tested in AD should also be examined in other chronic itch diseases (Ruzicka et al., 2017).”
BackgroundEpidermal Nerve Fiber Density: Normative Reference Range and Diagnostic Efficiency
McArthur, J. C., Stocks, E. A., Hauer, P., Cornblath, D. R., & Griffin, J. W. (1998) · Archives of Neurology · doi:10.1001/archneur.55.12.1513 · Cited by 560
TRPV1 Mediates Histamine-Induced Itching via the Activation of Phospholipase A2and 12-Lipoxygenase
Shim, W.-S., Tak, M.-H., Lee, M.-H., Kim, M., Kim, M., Koo, J.-Y., Lee, C.-H., Kim, M., & Oh, U. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4643-06.2007 · Cited by 465
The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis
Yosipovitch, G., Goon, A., Wee, J., Chan, Y. H., & Goh, C. L. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03829.x · Cited by 446
Self-citationLi, B., Tsoi, L. C., Swindell, W. R., Gudjonsson, J. E., Tejasvi, T., Johnston, A., Ding, J., Stuart, P. E., Xing, X., Kochkodan, J. J., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.28 · Cited by 397
Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
Ständer, S., Siepmann, D., Herrgott, I., Sunderkötter, C., & Luger, T. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010968 · Cited by 293
Suárez-Fariñas, M., Ungar, B., Correa da Rosa, J., Ewald, D. A., Rozenblit, M., Gonzalez, J., Xu, H., Zheng, X., Peng, X., Estrada, Y. D., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.003 · Cited by 268
Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema
Järvikallio, A., Harvima, I. T., & Naukkarinen, A. (2003) · Archives of Dermatological Research · doi:10.1007/s00403-002-0378-z · Cited by 234
Brain, S., Camp, R., Dowd, P., Black, A. K., & Greaves, M. (1984) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12261712 · Cited by 221
Yosipovitch, G., Goon, A. T. J., Wee, J., Chan, Y. H., Zucker, I., & Goh, C. L. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01460.x · Cited by 217
Self-citationIncreased number of immunoreactive nerve fibers in atopic dermatitis
Tobin, D., Nabarro, G., de la Faute, H. B., van Vloten, W. A., van der Putte, S. C. J., & Schuurman, H.-J. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90134-n · Cited by 211 · cited 1×
“SP has been shown to be involved in the mechanism of chronic itch in several disease states, including AD, prurigo nodularis, and PS (Amatya et al., 2011; Järvikallio et al., 2003; Pincelli et al., 1990; Tobin et al., 1992).”
BackgroundRuzicka, T., Simmet, T., Peskar, B. A., & Ring, J. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12284061 · Cited by 193
Dual action of neurokinin-1 antagonists on Mas-related GPCRs
Azimi, E., Reddy, V. B., Shade, K.-T. C., Anthony, R. M., Talbot, S., Pereira, P. J. S., & Lerner, E. A. (2016) · JCI Insight · doi:10.1172/jci.insight.89362 · Cited by 178
Itch characteristics in atopic dermatitis: results of a web-based questionnaire
Dawn, A., Papoiu, A. D. P., Chan, Y. H., Rapp, S. R., Rassette, N., & Yosipovitch, G. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08941.x · Cited by 176
Self-citationKavanaugh, A., Puig, L., Gottlieb, A. B., Ritchlin, C., You, Y., Li, S., Song, M., Randazzo, B., Rahman, P., & McInnes, I. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209068 · Cited by 162
Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study
PINCELLI, C., FANTINI, F., MASSIMI, P., GIROLOMONI, G., SEIDENARI, S., & GIANNETTI, A. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb06261.x · Cited by 153
Targeting Itch with Ligands Selective for κ Opioid Receptors
Cowan, A., Kehner, G. B., & Inan, S. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_16 · Cited by 117
Jabbari, A., Suárez‐Fariñas, M., Dewell, S. B., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.267 · Cited by 98
Chronic Pruritus: Current and Emerging Treatment Options
Pereira, M. P., & Ständer, S. (2017) · Drugs · doi:10.1007/s40265-017-0746-9 · Cited by 72
Expression of tachykinins and their receptors in plaque psoriasis with pruritus
Amatya, B., El‐Nour, H., Holst, M., Theodorsson, E., & Nordlind, K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10241.x · Cited by 64
Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation
Sarkar, M. K., Kaplan, N., Tsoi, L. C., Xing, X., Liang, Y., Swindell, W. R., Hoover, P., Aravind, M. S., Baida, G. E., Clark, M. R., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.972 · Cited by 54
Strober, B. E., Sigurgeirsson, B., Popp, G., Sinclair, R. D., Krell, J. M., Stonkus, S., Septe, M., Elewski, B. E., Gottlieb, A. B., Zhao, Y., et al. (2016) · International Journal of Dermatology · doi:10.1111/ijd.13236 · Cited by 46
Innovative Management of Pruritus
Feramisco, J. D., Berger, T. G., & Steinhoff, M. S. (2010) · Dermatologic Clinics · doi:10.1016/j.det.2010.03.004 · Cited by 41
Pruritus: an overview. What drives people to scratch an itch?
Lavery, M. J., Kinney, M. O., Mochizuki, H., Craig, J., & Yosipovitch, G. (2016) · PubMed Central · Cited by 38
Self-citation
Cited by
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Peripheral and Central Mechanisms of Itch
Dong, X., & Dong, X. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.023 · Cited by 378
Meixiong, J., Anderson, M., Limjunyawong, N., Sabbagh, M. F., Hu, E., Mack, M. R., Oetjen, L. K., Wang, F., Kim, B. S., & Dong, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.013 · Cited by 369
The Immunology of Psoriasis-Current Concepts in Pathogenesis
Sieminska, I., Pieniawska, M., & Grzywa, T. M. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08991-7 · Cited by 346
Itch: From mechanism to (novel) therapeutic approaches
Yosipovitch, G., Rosen, J. D., & Hashimoto, T. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.09.005 · Cited by 343
Self-citation
Metadata
- Authors
- Nattkemper, L. A., Tey, H. L., Valdes-Rodriguez, R., Lee, H., Mollanazar, N. K., Albornoz, C., Sanders, K. M., & Yosipovitch, G.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 138
- Issue
- 6
- Pages
- 1311-1317
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2781934223
- Cited by
- 310
- References
- 28
- FWCI
- 27.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.